Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05503771 · ClinicalTrials.gov registry record · NA
Improving Pediatrician Counseling About Infant Safe Sleep Using the Electronic Medical Record
A NA study of Sudden Infant Death and Sudden Unexplained Infant Death, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT05503771: Recruiting NA study of Sudden Infant Death and Sudden Unexplained Infant Death, sponsored by Johns Hopkins University.
NCT05503771 is a NA study of Sudden Infant Death and Sudden Unexplained Infant Death that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 350 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05503771, a NA study of Sudden Infant Death and Sudden Unexplained Infant Death, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
The study team will evaluate the impact of an Infant Sleep Assessment (ISA) tool with motivational interviewing (MI) communication training on clinician-parent communication during 2-month Well Baby Visits (WBV) and parent reported and observed infant sleep practices. The study team's hypotheses are that 1) clinicians who utilize the ISA with MI training will more effectively communicate safe sleep information to their patients' parents, and 2) these parents will have safer infant sleep practices than parents whose clinicians are in a standard of care control group.
Primary Outcome
To test the impact of implementing a new EMR-based Infant Sleep Assessment (ISA) on pediatric clinicians' delivery of anticipatory guidance (both positive and unintended negative consequences) after watching a self-paced video training on safe sleep information, ISA tutorial, and motivational interviewing
Conditions Studied
Interventions
- OTHER Standard of Care (SOC)
- BEHAVIORAL ISA-MI
Study Locations (1)
Maryland
- Harriet Lane Clinic - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2022-09-30 |
| Est. Completion | 2027-02-28 |
| Phase | NA |
What NCT05503771 shows while recruiting
NCT05503771 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 2 conditions, with Sudden Infant Death appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care (SOC) is the first listed.
NCT05503771 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT05503771 about?
NCT05503771 is a clinical study titled "Improving Pediatrician Counseling About Infant Safe Sleep Using the Electronic Medical Record". The study team will evaluate the impact of an Infant Sleep Assessment (ISA) tool with motivational interviewing (MI) communication training on clinician-parent communication during 2-month Well Baby Visits (WBV) and parent reported and observed infant sleep practices. The study team's hypotheses are...
What is the current status of trial NCT05503771?
This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2022-09-30. Estimated completion is 2027-02-28.
What conditions does trial NCT05503771 study?
This clinical trial studies the following conditions: Sudden Infant Death, Sudden Unexplained Infant Death.
What interventions are being tested in trial NCT05503771?
The interventions under investigation include: Standard of Care (SOC) (OTHER), ISA-MI (BEHAVIORAL).
Who is sponsoring clinical trial NCT05503771?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05503771 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sudden Infant Death
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05503771's enrollment target sits among peer trials
350 292nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI